Impact of pregnancy on prognosis of differentiated thyroid cancer: Clinical and molecular features

European Journal of Endocrinology

Volumn 170, Issue 5, 2014, Pages 659-666

  Messuti, Ilaria ^a   Corvisieri, Stefania ^a   Bardesono, Francesca ^a   Rapa, Ida ^a   Giorcelli, Jessica ^a   Pellerito, Riccardo ^a,b   Volante, Marco ^a   Orlandi, Fabio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MAURIZIANO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; B RAF KINASE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; B RAF KINASE GENE; CANCER PROGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; GENE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NIS GENE; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CELL TRANSFORMATION, NEOPLASTIC; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROGNOSIS; RADIOPHARMACEUTICALS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; YOUNG ADULT;

EID: 84899738508     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0903     Document Type: Article

References (19)

1. Mazzaferri EL, Robbins RJ, Spencer A, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2003 88 1433-1441. (doi:10.1210/jc.2002-021702
2. Durante C, Montesano T, Torlontano M, Attard M, Monzani F, Tumino S, Costante G, Meringolo D, Bruno R, Trulli F et al. Papillary thyroid cancer: time course of recurrences during postsurgery surveillance. Journal of Clinical Endocrinology and Metabolism 2013 98 636-642. (doi:10.1210/jc.2012-3401
3. Alves GV, Santin AP & Furlanetto TW. Prognosis of thyroid cancer related to pregnancy: a systematic review. Journal of Thyroid Research 2011 2011 691719. (doi:10.4061/2011/691719
4. Moosa M & Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. Journal of Clinical Endocrinology and Metabolism 1997 82 2862-2866. (doi:10.1210/jcem.82.9.4247
5. Yasmeen S, Cress R, Romano PS, Xing G, Berger-Chen S, Danielsen B & Smith LH. Thyroid cancer in pregnancy. International Journal of Gynaecology and Obstetrics 2005 91 15-20. (doi:10.1016/j.ijgo.2005. 06.022
6. Herzon FS, Morris DM, Segal MN, Rauch G & Parnell T. Coexistent thyroid cancer and pregnancy. Archives of Otolaryngology - Head and Neck Surgery 1994 120 1191-1193. (doi:10.1001/archotol.1994. 01880350009002
7. Vannucchi G, Perrino M, Rossi S, Colombo C, Vicentini L, Dazzi D, Beck-Peccoz P & Fugazzola L. Clinical and molecular features of differentiated thyroid cancer diagnosed during pregnancy. European Journal of Endocrinology 2010 162 145-151. (doi:10.1530/EJE-09-0761
8. Magri F, Capelli V, Rotondi M, Leporati P, La Manna L, Ruggiero R, Malovini A, Bellazzi R, Villani L & Chiovato L. Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk. Endocrine-Related Cancer 2012 19 463-471. (doi:10.1530/ERC-11-0389
9. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W & European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. European Journal of Endocrinology 2006 154 787-803. (doi:10.1530/eje.1.02158
10. Hedinger C. In Histological Typing of Thyroid Tumors: WHO International Histological Classification of Tumors, 2nd edn. Berlin-Heidelberg- New York: Springer-Verlag, 1988.
11. UICC. In TNM Classification of Malignant Tumours, 6th edn. New York: Wiley Liss, 2002.
12. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman SI & Tuttle RM. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006 16 109-142. (doi:10.1089/thy.2006.16.109
13. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L & Pinchera A. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Annals of Internal Medicine 2003 139 346-351. (doi:10.7326/0003-4819-139-5-Part-1-200309020-00010
14. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS & Nicoloff JT. Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1998 83 1121-1127. (doi:10.1210/jcem.83.4. 4683
15. Volante M, Rapa I, Gandhi M, Bussolati G, Giachino D, Papotti M & Nikiforov YE. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. Journal of Clinical Endocrinology and Metabolism 2009 94 4735-4741. (doi:10.1210/jc.2009- 1233
16. Ceppi P, Volante M, Novello S, Rapa I, Danenberg KD, Danenberg PV, Cambieri A, Selvaggi G, Saviozzi S, Calogero R et al. ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine. Annals of Oncology 2006 17 1818-1825. (doi:10.1093/annonc/mdl300
17. Webb RC, Howard RS, Stojadinovic A, Gaitonde DY, Wallace MK, Ahmed J & Burch HB. The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients. Journal of Clinical Endocrinology and Metabolism 2012 97 2754-2763. (doi:10.1210/jc. 2012-1533
18. Kim TH, Park YJ, Lim JA, Ahn HY, Lee EK, Lee YJ, Kim KW, Hahn SK, Youn YK, Kim KH et al. The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer 2012 118 1764-1773. (doi:10.1002/cncr.26500
19. Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011 21 1081-1125. (doi:10.1089/thy.2011.0087)